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Objective: Asthma diagnoses recorded in the Danish National Registry of Patients (DNRP) 
are a misclassified measure of the actual asthma status. We quantified this misclassification and 
examined its impact on the results of an epidemiologic study on asthma.
Study design and setting: We validated the DNRP asthma diagnoses against records of asthma 
diagnosed at medical examinations conducted during mandatory conscription evaluation. We 
had data on 22,177 male conscripts who were born from January 1st, 1977 to December 31st, 
1983, in a conscription district in northern Denmark. We obtained asthma diagnoses recorded 
among the conscripts in the DNRP from January 1st, 1977 through December 31st, 2003. We 
estimated sensitivity, specificity, and positive predictive value (PPV) of the DNRP asthma 
diagnoses. We then conducted sensitivity analysis to quantify the impact of nondifferential 
misclassification on the rate ratios measuring the association between asthma and risks of dif-
ferent skin cancers.
Results: The sensitivity of the DNRP for detecting an asthma diagnosis was 0.44 (95% confi-
dence interval [CI]: 0.42–0.47), the specificity was 0.98 (95% CI: 0.98–0.99) and the PPV was 
0.65 (95% CI: 0.62–0.68). Both direct and inverse associations between asthma and the different 
types of skin cancers became more pronounced after correcting for the misclassification.
Conclusion: The DNRP registered asthma diagnosis may be used to measure asthma status 
in epidemiologic studies seeking to estimate relative effects of asthma. Even at low values of 
DNRP sensitivity of asthma diagnoses were not sufficient to nullify observed relative associa-
tions in an actual dataset. The specificity of DNRP asthma diagnosis is high.
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Introduction
Asthma is a chronic disease that can present at any age, but the peak age of onset is 
around 6 years.1 Asthma, with a prevalence of 10%, is subject of many epidemiologic 
studies, and ascertainment of asthma commonly relies on hospital records. In order 
to draw valid inferences from such studies, the validity of the asthma diagnosis in 
hospital records needs to be quantified.2
Medical registries and databases are increasingly used as data sources in epide-
miologic research, including that of asthma. The Danish National Registry of Patients 
(DNRP) is a population electronic medical registry3 that records diagnoses made 
during hospital contacts. One study that used medical records as the gold standard to 
validate inpatient discharge diagnoses of asthma in the DNRP among children aged Clinical Epidemiology 2010:2 68
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6–14 years, reported a sensitivity of 90%, a specificity of 
99%, and a positive predictive value (PPV) of 85%.4 The 
validity of asthma diagnoses in the DNRP among adults 
has not been assessed, and neither has the validity of out-
patient clinic contacts and emergency department records 
of asthma.
We estimated sensitivity, specificity, and PPV of a 
recorded diagnosis of asthma in the DNRP against asthma 
diagnoses recorded among men presenting for their manda-
tory medical evaluation at the Danish military draft board. 
We then used the estimated sensitivity and specificity to 
examine the impact of asthma status misclassification on 
estimates from a study of the relation between asthma and 
risk of skin cancers.
Materials and methods
Study base
We conducted this study in the fifth military conscription 
district of Denmark,5 with geographic jurisdiction primarily 
over former North Jutland and Viborg counties (population 
of approximately 700,000 inhabitants, or 10% of the total 
Danish population). We had data on 22,177 men who were 
born from January 1st, 1977 to December 31st, 1983 in the 
conscription district and presented before the draft board 
authorities from January 1st, 1995 to December 31st, 2003. 
This dataset, known as the North Jutland conscription dataset, 
has been maintained at the Department of Clinical Epidemiol-
ogy, and used for various research projects.3
All men are draft liable in Denmark and are required 
by law to appear before the draft board at age 18 years for 
a mandatory medical evaluation to determine suitability to 
serve. Prior to actual appearance at the board, men receive 
a postal health questionnaire, in which they can report dis-
eases potentially precluding army service. The draft board 
authorities verify such reports either with each conscript’s 
healthcare provider or in an actual physical examination. 
All diagnoses established at conscription are recorded in 
the conscripts’ files regardless of whether they lead to army 
rejection. The draft board used the International Classifi-
cation of Diseases, 10th revision (ICD-10) to record the 
diagnoses during the study period. Because diagnoses at 
conscription are recorded after a formal verification or face 
to face contact with a physician, these asthma diagnoses 
at conscription were assumed to reflect the actual asthma 
status better than the DNRP and were therefore used as the 
gold standard for this study. A conscript was considered 
to have asthma if his file contained an ICD-10 diagnostic 
code J45.xx.
The Danish National Registry of Patients
Since 1977, Danish counties have maintained administrative 
information systems to monitor hospital admissions, collect-
ing information on dates of admission and discharge and 
up to 20 discharge diagnoses. Data from these information 
systems are transferred to the DNRP, which contains data 
on 99.4% of all discharge records from Danish hospitals.6 
From 1977 to 1993, discharge diagnoses have been coded 
according to the ICD-8, and thereafter according to the 
ICD-10.6 Since 1995, outpatient contacts and emergency 
room visits also have been recorded in addition to inpatient 
hospital stays. We obtained all asthma diagnoses among the 
conscripts recorded in the DNRP from January 1st, 1977 to 
December 31st, 2003.
Linkage of data sources
All public databases in Denmark uniquely identify persons 
by civil registration (CPR) number. This 10-digit number, 
encoding sex and date of birth, has been assigned at birth or 
emigration by the Danish Civil Registration System since 
1968.7 We used the CPR number to link DNRP records with 
the conscription records.
The cohort study of asthma  
and risk of skin cancers
To estimate the impact of misclassification of asthma coded 
in the DNRP on relative estimates in a cohort study, we 
used results of our unpublished nationwide cohort study, 
assessing the risk of skin cancers among asthmatic patients. 
We examined risks of malignant melanoma (MM), basal 
cell carcinoma (BCC) and squamous cell carcinoma (SCC), 
among 155,364 patients with a first time DNRP diagnosis 
of asthma recorded from 1977 through 2003. The asthma 
patients were followed for 1,168,944 person-years, while 
the skin cancers were ascertained by linkage to the Danish 
Cancer Registry. We calculated standardized incidence rate 
ratios (SIRR) for asthma, by dividing the case count among 
the asthmatics (observed) by the number of cases in the same 
amount of general population person time (expected). The 
observed SIRR were 0.87 (95% confidence intervals [CI]: 
0.74–1.03) for MM (144 observed vs. 165 expected cases), 
1.13 (95% CI: 1.05–1.20) for BCC (969 vs. 862), and 1.46 
(95% CI: 1.23–1.67) for SCC (176 vs. 123).
Statistical analyses
Sensitivity of the DNRP diagnosis of asthma was calculated 
as the proportion of men with a record of asthma at conscrip-
tion who also had an DNRP record of asthma (ICD-8 code Clinical Epidemiology 2010:2 69
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493.xx or ICD-10 code J45.xx). Specificity of the DNRP 
recorded asthma was calculated as the proportion of all men 
registered without record of asthma at conscription who 
also had no DNRP record of asthma. The PPV of a DNRP 
diagnosis of asthma was calculated as the proportion of all 
men registered with asthma in the DNRP, who also received 
asthma diagnosis at conscription. The PPV was calculated 
overall and by hospital contact type (inpatient stay, outpa-
tient clinic contact, emergency department visits). The main 
purpose with the PPV was to see any differences between 
inpatient stay coding, outpatient clinic contact coding, and 
emergency department visit coding.
We then used these estimates of sensitivity and specificity 
to correct for misclassification estimates of relative associa-
tions in the study of asthma and skin cancers. By design, 
the person time of asthma exposed and asthma unexposed 
was artificially set to be equal in order to calculate SIRR. 
This does not reflect the actual distribution of person time 
contributed by asthma patients to the general population, 
which is needed for a sensitivity analysis of misclassification 
impact. Therefore, we constructed hypothetical contingency 
tables from which regular IRR could be calculated. Following 
Greenland,8 we used the following general format to construct 
contingency tables (Table 1).
To these misclassified IRR estimates, we applied the point 
estimates of sensitivity and specificity to calculate corrected 
cell entries and IRR for each of the skin cancer types.9 We 
assumed that the rate of misclassification of asthma status was 
the same for patients with and without skin cancer (ie, non-
differential misclassification). We, then, estimated apparent 
IRR that would be observed for each of the outcomes under 
the different assumptions about sensitivity and specificity of 
the hospitalization records.10 In particular, we were interested 
in how severe a misclassification would produce an apparent 
absence of effect (ie, IRR = 1).
This study was approved by the Danish Data Protection 
Agency. The SAS statistical software package (version 9.2; 
SAS Institute Inc., Cary, NC) was used for all statistical 
analyses.
Results
Validity and predictive value of DNRP  
asthma diagnosis
Of the 1358 men with a diagnosis of asthma recorded 
at conscription, 604 men also had an asthma diagnosis 
recorded in the DNRP, resulting in a sensitivity of 0.44 
(95% CI: 0.42–0.47). Of the 20,819 men who did not have a 
diagnosis of asthma recorded at conscription 20,498 also did 
not have a diagnosis recorded in the DNRP. This resulted in 
a specificity of 0.98 (95% CI: 0.98–0.99) (Table 2).
A total of 925 of these men had a diagnosis of asthma 
coded in the DNRP, and of these, 604 men were also recorded 
in the conscription dataset with a diagnosis of asthma, result-
ing in a PPV of 0.65 (95% CI: 0.62–0.68) A total of 621 of 
the 925 asthma diagnosis codes were recorded as inpatients 
stays, 289 were recorded as outpatient visits, and 15 were 
emergency department visits. The PPV for an inpatient 
stay with asthma diagnosis was 0.65 (95% CI: 0.62–0.68), 
for an outpatient clinic contact 0.65 (95% CI: 0.62–0.69), 
and for an emergency department visit for asthma 0.73 
(95% CI: 0.51–0.96). For further details, see Table 3.
Consequences of application of observed validity on 
the cohort study of asthma and risk of skin cancers
Assuming the point estimates of the sensitivity and speci-
ficity of an asthma diagnosis in the DNRP (44% and 98%, 
Table 1 General format for contingency tables
Misclassified values Corrected values
Asthma Asthma
Yes No Total Yes No Total
Skin cancer cases A1* A0* A A1 A0 A
Person-years (PY) PY1* PY0* PY PY1 PY0 PY
IRR*=
A1*/PY1*
A0*/PY0*
IRR =
A1/PY1
A0/PY0
Table 2 Validity of the diagnosis codes of asthma in the DNPR, 
January 1st, 1977 to December 31st, 2003
Military Conscription Registry
Danish National  
Registry of Patients
With asthma  
diagnosis
Without asthma 
diagnosis
With asthma diagnosis 604 321
Without asthma  
diagnosis
754 20,498
Total 1,358 20,819
Sensitivity (95% CI): 604/1,358 = 0.44 (0.42–0.47)
Specificity (95% CI): 20,498/20,819 = 0.98 (0.98–0.99)
Abbreviations: CI, confidence intervals; DNRP, Danish National Registry of 
Patients.Clinical Epidemiology 2010:2 70
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Table 3 Positive predictive value of the diagnosis codes of asthma in the DNRP, January 1st, 1977 to December 31st, 2003 by hospital 
contact type
Danish National Registry of Patients
   Military conscription registry With asthma diagnosis Without asthma diagnosis
Asthma total With asthma diagnosis 604 754
Without asthma diagnosis 321 20,498
Total 925 21,252
PPV (95% CI): 604/925 = 0.65 (0.62–0.68)
Asthma hospitalization  
(ie, inpatient stay)
With asthma diagnosis 406 754
Without asthma diagnosis 215 20,498
Total 621 21,252
PPV (95% CI) 406/621 = 0.65 (0.62–0.69)
Asthma outpatient clinic contact With asthma diagnosis 187 754
Without asthma diagnosis 102 20,498
Total 289 21,252
PPV (95% CI) 187/289 = 0.65 (0.59–0.70)
Asthma emergency department visit With asthma diagnosis 11 754
Without asthma diagnosis 4 20,498
Total 15 21,252
  PPV (95% CI) 11/15 = 0.73 (0.51–0.96)
Abbreviations: CI, confidence interval; DNRP, Danish National Registry of Patients; PPV, positive predictive value.
Table 4 A–C The impact of misclassification on various risk estimates if the DNPR were used to identify asthma patients’ risk of skin 
cancers, misclassified and corrected for misclassification
Misclassified values Corrected values
Asthma Asthma
  Yes No Total Yes No Total
A. Malignant melanoma
Cases with asthma 6.00 159.00 165 7.85 157.15 165
Person-years at risk 48,744.96 1,120,199.04 1,168,944 69,847.59 1,099,096.41 1,168,944
  IRR* = 0.8679 IRR = 0.7862
B. Basal cell carcinoma
Cases with asthma 40.41 821.59 862 61.74 800.26 862
Person-years at risk 48,744.96 1,120,199.04 1,168,944 69,847.59 1,099,096.41 1,168,944
IRR* = 1.1302 IRR = 1.2140
C. Squamous cell  
carcinoma
Cases with asthma 7.34 115.66 123 12.42 123
Person-years at risk 48,744.96 1,120,199.04 1,168,944 69,847.59 1,099,096.41 1,168,944
  IRR* = 1.4582 IRR = 1.7669 
Abbreviation: IRR, incidence rate ratio.
respectively), a misclassified IRR of 0.87 for MM among 
asthma patients would decline to 0.79, if there was no asthma 
misclassification. Accordingly, a misclassified IRR of 1.13 
for BCC among asthma patients would increase to 1.21, if 
there was no asthma misclassification. Finally, a misclassified 
IRR of 1.46 for SCC among asthma patients would increase 
to 1.77, if there was no asthma misclassification. For further 
details, see Table 4A–C.
Figure 1A–C demonstrates the impact of misclassification 
of asthma diagnosis by the DNRP on estimates of IRR, using 
ranges of values of the sensitivity and specificity. In order 
to bring the apparent IRR to the value of 1 (ie, to produce Clinical Epidemiology 2010:2 71
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an apparent absence of effect), sensitivity of the DNRP in 
detecting asthma would need to be as low as 20%, combined 
with a specificity of 85%–90%. These estimates are much 
lower than those estimated in our analyses.
Discussion
The sensitivity of a recorded diagnosis of asthma in the 
DNRP was relatively low at 44%, while the specificity was 
high at 98%. The predictive value of such a recording did not 
vary by hospital contact type for asthma (ie, inpatient stay, 
outpatient clinic contact, emergency department visit). After 
applying the estimated sensitivity and specificity to an actual 
cohort study of asthma and risk of skin cancers, we found a 
more pronounced effect of both direct and inverse associa-
tions between asthma and the risk of skin cancers. Only a 
combined low sensitivity at 20% and specificity at 85% of 
an asthma diagnosis would be sufficient to nullify observed 
  relative associations. Both values fall well below the estimated 
sensitivity and specificity of the DNRP records.
Whether the data quality documented in our study is suf-
ficient for registry-based studies depends on the proposed 
research questions and study design used.11 If the DNRP 
data is used to assess changes in incidence of asthma over 
time, sensitivity and specificity must remain stable over 
time to obtain valid estimates. It is important that the 
misclassification of asthma is unrelated to information about 
earlier exposures or future outcomes (ie, nondifferential 
misclassification), if the DNRP data is are used in cohort or 
case control studies. We applied the estimates of sensitivity 
and specificity obtained in this validation study to the results 
of an actual study, in which we examined the association 
between asthma and risk of skin cancers (unpublished data). 
In this study, we found a 13% reduced risk of MM and 13% 
and 46% increased risk of BCC and SCC, respectively, 
among asthma patients. Assuming that the asthma misclassi-
fication is nondifferential with respect to skin cancer status, 
we showed that the numeric value of the corrected IRR for 
MM among asthma patients was reduced, while the numeric 
values IRR for BCC and SCC among asthma patients were 
increased without affecting the interpretation; in both cases, 
the corrected IRR estimate was further away from the value 
of 1.0 than the misclassified one. This corresponds to the 
statistical expectation that, given nondifferential misclas-
sification, corrected relative risk estimates are further away 
from the null than the uncorrected estimates.8 Had asthma 
been misclassified differentially with respect to skin cancer 
risk, the relative estimates could still be corrected but the 
direction of the bias would be unpredictable.12 Moreover, 
we assumed that the misclassification of skin cancer in the 
actual study was absent, which may not have been the case, 
resulting in an unpredictable direction of the bias.
There are several potential explanations for the degree of 
under-coding of asthma observed in this study, particularly 
compared with the 0.90 estimate of sensitivity in another 
Danish study.4 One explanation may be that the other Dan-
ish study validated the DNRP against medical records, 
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Figure 1A–C The impact of misclassification on various risk estimates if the Danish National Patient Registry were used to identify asthma patients’ risk of skin cancers for 
varying values of sensitivity and specificity.
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conventionally considered to be the best choice of a gold 
standard. Conscription records, used in this study as gold 
standard, are inferior to the actual medical records in that 
they themselves may under ascertain asthma diagnoses. That 
could happen if, for example, another medical condition has 
already been recorded as the primary reason for exemption. 
Furthermore, for a disease like asthma, with a considerable 
clinical spectrum and predominance in childhood, conscripts 
wanting to serve may not have reported mild cases or early life 
episodes of asthma. Therefore we may have underestimated 
the PPV of the DNRP by using conscript records as gold stan-
dard. Another explanation may be age, as the previous Dan-
ish study validated diagnosis of asthma among hospitalized 
asthmatic children aged 6–14 years.4 As the peak age of onset 
of asthma is six years,13 this diagnosis is the first one to be 
considered among children with obstructive lung symptoms 
in paediatric departments. Among adults, other diagnoses 
may be considered in a patient with first time obstructive lung 
symptoms. Finally, the asthma diagnosis code in the DNRP 
has been validated in a population of males who were born 
in 1977–1983, and therefore for them only inpatient stays 
with discharge diagnoses of asthma were recorded until 1995. 
Before 1995, diagnoses made during outpatient clinic visits 
were not recorded in the DNRP. This, together with the fact 
that asthma diagnoses made outside hospitals (ie, at general 
practitioners) may have contributed to the low sensitivity of 
the asthma diagnoses coding in the DNRP.
In conclusion, we considered a single case of the effect 
of exposure misclassification on the magnitude of apparent 
IRR. The low sensitivity of the DNRP ascertained asthma 
diagnosis is not sufficient to nullify observed relative associa-
tions in the actual dataset, and the specificity of DNRP asthma 
diagnosis is high. While nondifferential misclassification of 
a dichotomous exposure is expected to produce bias towards 
the null, provided there is an association, the magnitude of 
resulting bias may differ depending on characteristics of 
exposure and the association under study,10 and needs to be 
assessed individually.
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